Browsing: weight-loss and diet control industry
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
Patients could wean themselves off blockbuster obesity drugs such as Ozempic or Wegovy without piling the pounds back on, according…
It’s now illegal to sell weight-loss and muscle-building supplements to minors in New York, under a first-in-the-nation law that went into effect…
Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked…
You know exercise is good for your health, but life can get in the way of your physical fitness. Perhaps…
WeightWatchers, reeling from collapsing stock and Oprah’s departure in the age of Ozempic, vows to ‘prove the naysayers wrong’ and turn its fortunes around
The CEO at WW International, also known as WeightWatchers, told employees in a memo today that the company is on…
The company claims to have helped more than four million people lose weight and it’s tagline is “Go Lose Weight,…
Oprah will leave the Weight Watchers board and donate her stake in the company ‘to eliminate any perceived conflict of interest around her taking weight loss medications’
Oprah Winfrey is standing down from the board of WW International, also known as WeightWatchers, and the reason why has…
Novo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out-of-pocket for them
The popularity of Novo Nordisk’s weight-loss drugs has been unprecedented and has shown no signs of fading. It’s clearly more…
The 10 top 2024 wellness trends leading Americans to spend over $5,300 a year on their well-being
According to the Global Wellness Summit’s 2024 trends report from the Global Wellness Institute, which combines research and insights from…
Novo Nordisk hits $500bn market value, climbing closer to the $1tn club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
Novo Nordisk has shown few signs of slowing down since taking the pharmaceutical world by storm last year. Now, the…